Terry-Ann Burrell, Director of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 13 sales on the open market. The latest trade was on 24/07/01.

TB

TB

Terry-Ann Burrell

Director

Company

Recursion Pharmaceuticals RXRX

First filing

23/01/05

Trades

37 trades

Buys / sales

0 / 13

12-month net buying

No record

Last trade

24/07/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/04/01	24/04/03	5,446 sh	$32.12	$174,925.52	−7.2%
Recursion PharmaceuticalsRXRX	Open-market sale	23/07/12–23/07/13	23/07/14	117,000 sh5 trades	$12.07avg.	$1,412,703.06	−68.1%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	23/04/03–23/04/04	23/04/05	4,640 sh2 trades	$29.74avg.	$137,971.48	−9.0%
Beam TherapeuticsBEAM	Open-market sale	23/01/26–23/01/27	23/01/30	37,254 sh2 trades	$45.08avg.	$1,679,498.48	−54.4%
Beam TherapeuticsBEAM	Open-market sale	23/01/23–23/01/24	23/01/25	20,236 sh2 trades	$45.01avg.	$910,876.62	−39.3%
Beam TherapeuticsBEAM	Open-market sale	23/01/18	23/01/20	47,195 sh	$45.14	$2,130,382.3	−60.1%